There are currently 298 active clinical trials seeking participants for Cancer research studies. The states with the highest number of trials for Cancer participants are California, Texas, New York and Florida.
Immune Reconstitution in Stem Cell Transplant Recipients
NCT02129543
Recruiting
This specimen collection lab protocol will allow the investigators to prospectively study immune reconstitution in patients being treated for hematologic disorders and immune factors affecting graft versus host disease in stem-cell transplant (SCT) patients.
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
10/10/2023
Locations: University of Miami, Miami, Florida
Conditions: Cancer
Register for Updates
EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer
NCT06083324
Recruiting
This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.
Gender:
All
Ages:
Between 20 years and 89 years
Trial Updated:
10/09/2023
Locations: AHN CI Exercise Oncology and Resiliency Center, Pittsburgh, Pennsylvania
Conditions: Cancer
Register for Updates
Obstruction of Malignancy: Percutaneous Renal vs Endoscopic Stent
NCT05640115
Recruiting
This research study will compare two procedures commonly used to treat urinary obstruction due to cancer. Sometimes cancer blocks one or both ureters (narrow tubes in the body that carry urine from the kidneys to the bladder). When these ureters become blocked, the body can no longer properly drain urine. This blocking of the ureters is called urinary obstruction, which can lead to kidney problems, infection, and pain. Treatment options for urinary obstruction include ureteral stent placement an... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/05/2023
Locations: The University of Chicago, Chicago, Illinois
Conditions: Cancer, Urinary Obstruction, Malignancy, Urinary Dysfunction, Ureter Obstruction, Ureter Injury
Register for Updates
Device Feasibility and Acceptability to Improve Insomnia in Cancer
NCT05875129
Recruiting
Sleep disruption is common among young adult cancer survivors for a variety of reasons. Cognitive behavioral therapy for insomnia (CBT-I) has been shown to improve chronic sleep disorders. This project will test the feasibility and acceptability of a new voice-activated virtual assistant (VAVA) device to deliver CBT-I to improve sleep among young adult cancer survivors with chronic sleep disorders.
Gender:
All
Ages:
Between 18 years and 39 years
Trial Updated:
10/04/2023
Locations: MedStar Washington Hospital Center, Washington, District of Columbia
Conditions: Cancer, Insomnia Chronic
Register for Updates
Cannabis Use and Outcomes in Black and White Patients With Cancer
NCT06037681
Recruiting
The goal of the observational study is to learn how black and white patients with solid tumor cancer use cannabis, opioids and tobacco. The investigators are using momentary ecological assessment through a smart phone app and surveys to assess patient-reported pain and other symptoms as to inform clinical practice and guidelines for underrepresented populations.
Gender:
All
Ages:
Between 21 years and 99 years
Trial Updated:
09/27/2023
Locations: University at Buffalo, Buffalo, New York +2 locations
Conditions: Cancer
Register for Updates
NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors
NCT04656496
Recruiting
Pediatric cancer survivors are at an increased risk of excessive weight gain and reduced exercise behaviors with the potential for this risk to worsen over time. With over 80% of pediatric cancer patients living to adulthood, many pediatric cancer survivors experience long-term health consequences such as heart disease - the leading cause of death in this population. The purpose of this clinical research study is to teach parents/caregivers skills that will help prevent and reduce the problems... Read More
Gender:
All
Ages:
Between 5 years and 14 years
Trial Updated:
09/26/2023
Locations: Children's National Hospital, Washington, District of Columbia +9 locations
Conditions: Obesity, Childhood, Cancer, Survivorship
Register for Updates
A Study of Physical Activity in Cancer Survivors
NCT05988892
Recruiting
The purpose of this study is to determine if increasing physical activity (PA) will increase physical functioning, as measured by cardiovascular endurance, muscular strength, and balance in underserved adult cancer survivors > 60 years of age and/or those of any age residing at a rural address. Also, to determine if increasing PA will increase quality of life (QOL), as measured by physical functioning and fatigue, in underserved cancer survivors >60 years of age and/or those of any age residing... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
09/26/2023
Locations: Mayo Clinic Health System-Eau Claire Clinic, Eau Claire, Wisconsin
Conditions: Cancer
Register for Updates
"Prescribing" Exercise to Cancer Patients at High-Risk for Falls
NCT04236154
Recruiting
Falls are common and catastrophic in cancer patients. Cancer patients are vulnerable to falls due to muscle loss. In prescribing exercise in a data driven manner to cancer patients, our hypothesis is this "prescription" for exercise will eventually be demonstrated to reduce the occurrence of injurious falls.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/25/2023
Locations: Mayo Clinic, Rochester, Minnesota
Conditions: Cancer
Register for Updates
Booster Dose Trial
NCT05016622
Recruiting
The goal of this study is to assess the safety and effectiveness of a COVID vaccine booster in patients with cancer who have not developed an antibody after the U.S. Food and Drug Administration (FDA) Emergency Use Authorized COVID vaccination series
Gender:
All
Ages:
18 years and above
Trial Updated:
09/18/2023
Locations: Montefiore Medical Center, Bronx, New York
Conditions: Cancer
Register for Updates
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
NCT05163028
Recruiting
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS or EGFR mutations to determine the maximum tolerated dose and recommended Phase II dose of HBI-2376 and characterize its pharmacokinetic profile.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/12/2023
Locations: City of Hope, Duarte, California +11 locations
Conditions: Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Solid Tumor, Cancer, Cancer of Pancreas, Cancer of Colon
Register for Updates
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation
NCT05485974
Recruiting
A Phase 1 dose escalation study in patients with advanced solid tumors harboring KRAS G12C mutation to determine the maximum tolerated dose and recommended Phase II dose of HBI-2438 and characterize its pharmacokinetic profile.
Gender:
All
Ages:
18 years and above
Trial Updated:
09/12/2023
Locations: California Cancer Associates for Research and Excellence, Inc. (cCare), Encinitas, California +13 locations
Conditions: Lung Cancer, Non Small Cell Lung Cancer, Colorectal Cancer, Cancer of Pancreas, Colon Cancer, Solid Tumor, Cancer
Register for Updates
Patient-Reported Outcome Version of the Common Criteria for Adverse Events
NCT04050072
Recruiting
Childhood cancer survivors are vulnerable to treatment-related late effects, including physical and psychosocial morbidities, subsequent malignancies, and premature death. Symptom assessment provides a unique insight into survivorship care since symptoms not only indicate the manifestation for the occurrence of chronic health conditions, but also impact quality of life and survival. The National Cancer Institute (NCI) has developed a Patient-Reported Outcomes version of the Common Terminology Cr... Read More
Gender:
All
Ages:
16 years and above
Trial Updated:
09/06/2023
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee
Conditions: Survivorship, Cancer
Register for Updates